FDA Approved Medical Products for:

Mucopolysaccharidosis type II

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Idursulfase
Trade Name
(Manufacturer Name)
The FDA has approved this product to be used in this manner.
Indicated for patients with Hunter syndrome (mucopolysaccharidosis II, MPS II). Idursulfase has been shown to improve walking capacity in these patients
More Information about this product Drug Information Portal